CD4 and Hepatitis: Our inability to detect CMV in baseline serum samples from CD4+ TEMhigh patients or liver biopsies from patients with high-grade hepatitis is a challenge for our theory; however, it may simply be beyond our technical capability to detect very low levels of compartmentalised viral reactivation.